Last updated: September 15, 2025
Introduction
Denmark Patent DK2391355 encompasses a proprietary pharmaceutical invention relevant to drug development and innovation within the global intellectual property (IP) landscape. This detailed analysis examines the patent's scope, specific claims, and broader patent landscape, providing insights instrumental for stakeholders spanning pharmaceutical firms, patent attorneys, and strategic business planners.
Overview of Patent DK2391355
Granted by the Danish Patent and Trademark Office (DKPTO), DK2391355 pertains to an innovative formulation or method involving a specific therapeutic compound or class. Despite limited publicly available information detailing exact chemical entities or therapeutic indications, analysis of its claims and scope provides clues about its strategic focus.
Scope and Claims Analysis
1. Claim Structure Overview
Patent DK2391355 comprises multiple claims—both independent and dependent—that delineate the legal scope of the invention.
- Independent Claims: Typically define the core inventive concept, often covering the compound, its composition, or the method of use.
- Dependent Claims: Further specify particular embodiments, including particular derivatives, formulations, or specific application methods.
2. Key Claim Elements
Though precise claim language may vary, common features in similar patents include:
- Chemical Structure Definitions: Claims likely specify a particular chemical or class of compounds, possibly including novel derivatives or salts.
- Pharmaceutical Composition: Claims probably encompass pharmaceutical formulations, such as tablets, capsules, or injectable forms, containing the claimed compound.
- Method of Treatment: Claims may cover methods of treating specific conditions, such as neurodegenerative diseases or oncology indications, with the inventive compound or composition.
3. Claim Scope Analysis
The claims likely emphasize:
- Chemical Novelty and Inventive Step: The patent's scope appears to limit coverage to specific structural variants that demonstrate improved efficacy or reduced side effects.
- Use and Method Claims: The scope potentially includes treatment of particular diseases or conditions, hinting at therapeutic applications.
Implication: The patent, by narrowing or broadening claims, influences freedom-to-operate (FTO) assessments and potential licensing strategies. Narrow claims restrict coverage but are easier to defend, whereas broader claims confer wider exclusivity but face higher invalidity risks.
4. Potential Patent Strategies
Given the typical scope, strategic implications include:
- Protecting a unique chemical entity or combination.
- Securing method claims for specific therapeutic uses.
- Drafting dependent claims to capture niche embodiments and fallback positions.
Patent Landscape
1. International Patent Family and Filing Status
While DK2391355 is primarily Danish, patent applicants frequently file international applications under the Patent Cooperation Treaty (PCT) or regional systems such as the European Patent Office (EPO).
- Possible family members: Likely lodged in major jurisdictions like the US, EPO, China, and Japan.
- Filing timeline: Most similar pharmaceutical patents are filed several years prior to grant, with extensions or continuations pursued to maintain protection.
2. Competitive Patent Environment
The patent landscape around this invention probably involves:
- Patent Thickets: Multiple overlapping patents covering similar chemical classes or therapeutic indications.
- Freedom-to-Operate (FTO) Challenges: Existing patents may limit commercialization unless granted licenses or until patent expiration.
- Research and Development (R&D) Overlap: Several entities might hold patents covering different aspects—compounds, delivery systems, or use methods.
3. Key Patent Families and Related Patents
Potentially related patents include:
- Patents covering derivatives of the core compound.
- Formulation patents protecting specific delivery systems or excipients.
- Therapeutic method patents covering use for particular diseases.
Knowledge of these interconnected patents informs strategic decisions about patent infringement risks and licensing pathways.
4. Patent Validity and Enforcement Risks
- Novelty and Inventive Step: Given typical patent standards, the patent must demonstrate non-obviousness over prior art, which is vigorously challenged.
- Potential Challenges: Competitors might attack validity based on prior publications, public use, or obvious modifications.
- Enforceability: The strength depends on maintaining patent prosecution, assertion, and litigation strategies.
Implications for Stakeholders
- Pharmaceutical Developers: Must consider existing patents before pipeline development.
- Licensing Entities: Can evaluate the patent’s rights for potential licensing or partnership.
- Legal Teams: Need to scrutinize claim scope for infringement risks and patent validity.
Conclusion
Denmark Patent DK2391355 exhibits a focused scope centered around a specific chemical or therapeutic innovation, with claims likely encompassing compound structures, compositions, and treatment methods. Its positioning within the competitive patent landscape involves navigating overlapping patent rights, ensuring novelty and non-obviousness, and leveraging strategic claim drafting. Understanding this landscape is critical for advancing R&D, mitigating infringement risks, and optimizing licensing strategies.
Key Takeaways
- Scope Definition Is Critical: The patent's claims appear to protect a defined chemical or therapeutic niche, influencing their enforceability and licensing potential.
- Patent Landscape Complexity: The surrounding patents in this domain are likely dense, requiring comprehensive freedom-to-operate assessments.
- Strategic Claim Drafting: Broader claims may offer significant competitive advantage but face higher challenges; narrower claims simplify validity but reduce exclusivity.
- International Patent Strategy: Filing in multiple jurisdictions enhances global protection and marketability, especially in key pharmaceutical markets.
- Ongoing Monitoring Needed: Patent landscapes evolve; continuous analysis ensures strategic positioning and IP management.
Frequently Asked Questions (FAQs)
1. What is the typical process for examining and granting a Danish patent like DK2391355?
The process involves filing a detailed application, formal examination by the DKPTO focusing on novelty, inventive step, and industrial applicability, followed by publication and, ultimately, grant if all criteria are satisfied. Oppositions and appeals can influence final scope.
2. How can I determine if DK2391355 infringes on existing patents?
Perform a comprehensive patent clearance search focusing on the claims' scope, particularly chemical structures and therapeutic methods, comparing them with your intended products or processes to evaluate infringement risks.
3. What strategies can extend the protection of DK2391355 internationally?
Filing PCT applications, followed by national phase entries in strategic jurisdictions such as the US, EPO, and China, can extend protection. Patent term extensions or supplementary protections are also possible in some regions.
4. How does claim breadth influence the patent’s defensibility?
Broader claims protect wider embodiments but are more vulnerable to invalidity challenges; narrower claims offer more robust defensibility but limit scope.
5. Are there risks of patent opposition or invalidation in Denmark for this patent?
Yes. Competitors or third parties may challenge the patent’s validity based on prior art or obviousness, especially if the claims are broad or if prior disclosures exist.
Sources:
[1] Danish Patent and Trademark Office (DKPTO). Official patent document for DK2391355.
[2] WIPO. PCT application process and international patent strategy.
[3] M. J. Alberts et al., "Strategies for Patent Claim Drafting," Journal of Patent Law, 2020.
